{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:20Z","timestamp":1792784480795,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Program for Liaoning Innovative Research Team in University","award":["LT2013019"],"award-info":[{"award-number":["LT2013019"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.phrs.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T09:46:38Z","timestamp":1462441598000},"page":"90-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis"],"prefix":"10.1016","volume":"108","author":[{"given":"Xufeng","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.05.003_bib0005","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis","volume":"367","author":"Sambrook","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.05.003_bib0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrrheum.2011.130","article-title":"New targets for intervention in the treatment of postmenopausal osteoporosis","volume":"7","author":"Lewiecki","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrrheum.2012.120","article-title":"Osteoporosis\u2013a risk factor for cardiovascular disease?","volume":"8","author":"Lampropoulos","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrendo.2011.146","article-title":"Antiresorptive therapies for osteoporosis: a clinical overview","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.03.003","article-title":"Osteoporosis medication adherence: physician perceptions vs. patients\u2019 utilization","volume":"55","author":"Curtis","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2016.05.003_bib0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.phrs.2016.05.003_bib0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.05.003_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2016.05.003_bib0045","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncprheum0298","article-title":"Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus","volume":"2","author":"Lane","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0050","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.05.003_bib0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-\u03b1\/IL-1: interrelations in bone resorption pathophysiology","volume":"15","author":"Kwan Tat","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phrs.2016.05.003_bib0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ncpendmet0325","article-title":"Drug insight: existing and emerging therapies for osteoporosis","volume":"2","author":"Mulder","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.05.003_bib0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.05.003_bib0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00774-014-0596-4","article-title":"The protective effect of lycopene intake on bone loss in ovariectomized rats","volume":"33","author":"Iimura","year":"2015","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.phrs.2016.05.003_bib0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00774-010-0187-y","article-title":"Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension","volume":"29","author":"Habold","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.phrs.2016.05.003_bib0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bone.2014.06.010","article-title":"Ginsenoside-Rb2 displays anti- osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis","volume":"66","author":"Huang","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2016.05.003_bib0085","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbamem.2012.12.010","article-title":"The antifungal activity and membrane-disruptive action of dioscin extracted from Dioscorea nipponica","volume":"1828","author":"Cho","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.05.003_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virusres.2012.12.001","article-title":"Dioscin\u2019s antiviral effect in vitro","volume":"172","author":"Liu","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.phrs.2016.05.003_bib0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00204-013-1148-8","article-title":"Protective effects of dioscin against alcohol-induced liver injury","volume":"88","author":"Xu","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0030-1250461","article-title":"Application of proteomic and bioinformatic techniques for studying the hepatopotective effect of dioscin against CCl4-induced liver damage in mice","volume":"77","author":"Lu","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.phrs.2016.05.003_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxlet.2012.08.005","article-title":"Dioscin a natural steroid saponin, shows remarkable protective effect against acetaminophen-induced liver damage in vitro and in vivo","volume":"214","author":"Zhao","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2016.05.003_bib0110","doi-asserted-by":"crossref","first-page":"30704","DOI":"10.1039\/C4RA03948C","article-title":"iTRAQ-based proteomics for studying the effects of dioscin against nonalcoholic fatty liver disease in rats","volume":"4","author":"Xu","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.phrs.2016.05.003_bib0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/pmic.201300101","article-title":"iTRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells","volume":"14","author":"Chen","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.phrs.2016.05.003_bib0120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.fct.2013.07.012","article-title":"Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: a potential new drug for treatment of glioblastoma multiforme","volume":"59","author":"Lv","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/TP.0000000000000262","article-title":"Dioscin attenuates hepatic ischemia- reperfusion injury in rats through inhibition of oxidative-nitrative stress, inflammation and apoptosis","volume":"98","author":"Tao","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2016.05.003_bib0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.freeradbiomed.2015.03.003","article-title":"Dioscin ameliorates cerebral ischemia\/reperfusion injury through the down-regulation of TLR4 signaling via HMGB-1 inhibition","volume":"84","author":"Tao","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2016.05.003_bib0135","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1038\/srep07973","article-title":"Potent effects of dioscin against obesity in mice","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2016.05.003_bib0140","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1038\/srep09713","article-title":"Potent effects of dioscin against liver fibrosis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2016.05.003_bib0145","doi-asserted-by":"crossref","first-page":"11064","DOI":"10.1039\/C4CC09160D","article-title":"Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats","volume":"51","author":"Zhang","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.phrs.2016.05.003_bib0150","doi-asserted-by":"crossref","first-page":"54026","DOI":"10.1039\/C4RA09160D","article-title":"Inhibitory effects of dioscin on cytochrome P450 enzymes","volume":"4","author":"Tao","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.phrs.2016.05.003_bib0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1423-0127-21-30","article-title":"Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines","volume":"21","author":"Zhang","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.phrs.2016.05.003_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1365\/s10337-009-1407-2","article-title":"An economical method for isolation of dioscin from Dioscorea nipponica Makino by HSCCC coupled with ELSD, and a computer-aided UNIFAC mathematical model","volume":"71","author":"Yin","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.phrs.2016.05.003_bib0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cej.2010.09.045","article-title":"A green and efficient protocol for industrial-scale preparation of dioscin from Dioscorea nipponica Makino by two-step macroporous resin column chromatography","volume":"165","author":"Yin","year":"2010","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.phrs.2016.05.003_bib0170","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/MCB.01225-12","article-title":"TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis","volume":"33","author":"Lamothe","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0175","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.chembiol.2007.06.010","article-title":"A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNF-\u03b1 signaling pathways","volume":"14","author":"Qiu","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0180","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.305.5689.1420","article-title":"Coming to grips with bone loss","volume":"305","author":"Marx","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.05.003_bib0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature01654","article-title":"The complexities of skeletal biology","volume":"423","author":"Karsenty","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.05.003_bib0190","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/416686a","article-title":"Medicine: interfering with bone remodeling","volume":"416","author":"Alliston","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.05.003_bib0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bone.2008.08.127","article-title":"Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats","volume":"45","author":"Zhang","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2016.05.003_bib0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2010.05.016","article-title":"Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice","volume":"325","author":"Tyagi","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.05.003_bib0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.05.003_bib0215","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","article-title":"Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals","volume":"132","author":"Shinohara","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.05.003_bib0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phrs.2016.05.003_bib0225","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.micpath.2014.03.006","article-title":"TLR4 in Toxoplasmosis; friends or foe?","volume":"69\u201370","author":"Zare-Bidaki","year":"2014","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.phrs.2016.05.003_bib0230","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.neuropharm.2014.01.022","article-title":"Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1\/IKK\/NF-\u03baB, MAPKs and Akt signaling pathways","volume":"79","author":"Wang","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.05.003_bib0235","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.archoralbio.2011.05.010","article-title":"n-Butanol extracts of Panax notoginseng suppress LPS induced MMP-2 expression in periodontal ligament fibroblasts and inhibit osteoclastogenesis by suppressing MAPK in LPS-activated RAW264.7 cells","volume":"56","author":"Jang","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.phrs.2016.05.003_bib0240","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/bph.12463","article-title":"Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo","volume":"171","author":"Zhai","year":"2014","journal-title":"Br. J. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.phrs.2019.104397","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000}},{"DOI":"10.1016\/j.phrs.2023.106894","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815301705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815301705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:53:07Z","timestamp":1760910787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661815301705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":48,"alternative-id":["S1043661815301705"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.003","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}